Loading clinical trials...
Loading clinical trials...
The OptimaMed Intervention to Reduce Inappropriate Medications in Long-term Care Residents With Severe Dementia: Results From a Quasi-experimental Intervention Study
An education intervention to promote medication reviews and interdisciplinary discussions within long-term care facilities with the aim of improving medication regimen among residents with severe dementia
A quasi-experimental study in three long-term care facilities. The intervention comprises an information leaflet for families of residents, a 90-minute knowledge exchange session for general practitioners, pharmacists and nurses and a list of "generally", "sometimes", and "exceptionally" appropriate medications for severe dementia residents
Age
65 - No limit years
Sex
ALL
Healthy Volunteers
No
Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
Québec, Canada
Start Date
March 1, 2014
Primary Completion Date
October 1, 2014
Completion Date
December 1, 2015
Last Updated
June 1, 2018
44
ACTUAL participants
Knowledge exchange
BEHAVIORAL
Lead Sponsor
CHU de Quebec-Universite Laval
Collaborators
NCT04246437
NCT05508789
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions